红花及主要药效物质治疗糖尿病肾病机制研究进展  

Research progress on anti-diabetic nephropathy effect of safflower and its main active Ingredients

作　　者：胡娜平 李会会[1,2] 鹿成韬[2] 李健康[2] 李帆[2] 文爱东[1,2] 

机构地区：[1]陕西中医学院药学院,陕西咸阳712046 [2]第四军医大学西京医院,陕西西安710032

出　　处：《时珍国医国药》2015年第9期2223-2225,共3页Lishizhen Medicine and Materia Medica Research

基　　金：国家自然科学基金(No.81373947;No.81302695)

摘　　要：糖尿病肾病(diabetic nephropathy,DN)是糖尿病(diabetes mellitus,DM)最常见最严重的微血管并发症,是糖尿病患者死亡的重要原因。近年来,传统中药红花及其主要药效物质红花黄色素在改善和治疗糖尿病肾病方面越来越多的关注。分析总结红花及其主要药效物质在治疗糖尿病肾病方面的相关作用机制,对红花治疗糖尿病肾病作用机制的进一步研究有重要意义。Diabetic nephropathy （DN） is the most common serious microvascular complication of diabetes mellitus （ DM）, and an important cause of mortality in patients with diabetes as well. In recent years, safflower, a traditional Chinese medicine and its primary active component safflower yellow on diabetic nephropathy treatment have raised more and more attention. The elucidation of the potential various mechanism of safflower and its main efficacy material in the treatment of diabetic nephropathy is meaningful for further study.

关 键 词：红花 红花黄色素 糖尿病肾病 

分 类 号：R285.5[医药卫生—中药学] R259[医药卫生—中医学]